A three-hour Elizabeth Holmes film just broke the box office rulebook

What if the most bankable thing in theaters right now is a nearly three-hour documentary in which a comedian spends time with Elizabeth Holmes? That sentence would have sounded like a pitch for a bad joke a year ago. Today it describes a box office story that the industry should study closely.

Here is what happened. A24's You Can See Everything, from Nathan Fielder and Lance Oppenheim, opened to an estimated $15 million from 855 theaters. That is far above the $7 million to $10 million range that trade publications had projected. Then it expanded to roughly 2,600 locations. Deadline reports that Clayface took No. 1 with $24 million-plus, while the documentary was heading for a possible $20 million second weekend. The Hollywood Reporter has it at $6.1 million on Friday alone, for a $31.7 million domestic total.

A second weekend that beats the opening, if that projection holds, is the rare part. Wide expansion helps, of course: it roughly tripled the theater count. Still, the film has to fill those new seats, and so far it looks like it is doing that. Everything else in this column follows from that.

Word of mouth beat the marketing plan

Look at how the audience talks about it. As Mashable collected, viewers describe the runtime as part of the experience. One wrote that the film "becomes more riveting with every passing hour." Another praised a theater where everyone was "locked tf in." Another said the shared reactions made it better.

That is the thing a streaming queue cannot replicate. A communal gasp at the same moment is a reason to buy a ticket, and nobody can pause it. We think that matters more than any single stat. A long, strange film gave people a reason to leave the couch, and they told their friends.

The scores helped, naturally. Mashable notes a 98 percent on Rotten Tomatoes and the top spot on Letterboxd. Skeptics exist too: some Letterboxd reviewers called it "boring and painfully long." We find that reassuring. A film that everybody mildly likes doesn't build this kind of conversation. A film people argue about does.

Length and weirdness were the product, not the problem

The standard studio instinct is to trim. Two hours is safe, three is a scheduling problem, and a documentary is a niche. This film ignores all three rules. The In Review Online critic calls it Fielder's "opus" and describes a structure that shifts halfway through, when Holmes begins her sentence and the film turns into a study of how a character gets constructed. That is not a conventional documentary, and nobody would call it a safe one.

Our view: the distinct voice is what sold it. Fielder's name carries a specific promise, a deadpan strangeness you can't mistake for anything else. A24 also built the event carefully, with a surprise Telluride screening and a teaser on September 6, then an official trailer on September 23. That looks to us like a patient, almost franchise-style rollout, applied to an original idea. The lesson isn't "make everything long." It's that identity is a marketing asset, and sanding it down costs you.

Don't oversell it, but don't dismiss it

Some caution is fair. This is a topical subject with a famous name attached, and a hype cycle can cool. Reviews aren't unanimous either: Time's Stephanie Zacharek wrote that "there's almost too much to unpack, if you can be bothered to care about any of it." ScreenRant has also listed things the film leaves out about Holmes. Those are fair criticisms, and they may even feed the discussion further.

We also wouldn't promise that every three-hour oddity will repeat this. Oscar chatter, including prediction-market talk of a Best Picture run, is speculation for now. The film's own success may be hard to copy.

But the takeaway for studios is simpler than copying. Stop treating a film's unusual qualities as risks to be managed. The audience here seems to have treated them as the reason to show up. Executives who keep asking "can we cut forty minutes?" should first ask whether those forty minutes are what people are buying.

Our verdict: this is probably the most useful box office data point of the fall. Not because documentaries will suddenly rival superhero films, but because it shows an audience hungry for something with a point of view. If you're curious, go see it in a theater, with a crowd. That's apparently where it works best.